In face of the war against novel coronavirus, MGI’s DNBSEQ series of high-throughput sequencers are used in pneumonia prevention phenomena and control such as genome sequence assembly, suspected patient detection, and mutation detection. DNBSEQ-G400 became one of the first coronavirus genome sequencers to be released. DNBSEQ-G400, as a high-throughput sequencer, is widely used in clinical and scientific research. It plays an important role in sequencing localized data across the country...

On January 26, 2020, the National Medical Products Administration approved the new detection products of four enterprises in the fight against the 2019 novel coronavirus (2019-nCoV), including MGI’s ultra-high-throughput sequencer DNBSEQ-T7, which received certification as a Class III Medical Device. DNBSEQ-G400 helps trace new coronavirus In June 2018, DNBSEQ-G400 [1] sequencer made by MGI was approved by the National Medical Products Administration, and has been widely used in clinica...

BGI is bringing its full genomics expertise and resources to the front lines in the fight against the 2019 novel coronavirus. BGI has scaled up production of its new real-time fluorescent RT-PCR kits for detecting the virus, known as 2019-nCoV, donating 20,000 kits to support the response in Wuhan and Hubei Province. The test can issue results in a few hours. BGI has now released about than 50,000 test kits to hospitals and disease control centers around China. BGI Chairman and Co-Found...

Recently, the first meeting of the "Million Microbiome of Humans Project (MMHP)" International Cooperation Program was held in the National Gene Bank of Shenzhen. This program is currently the world's largest international microecology research program, and is committed to the protection of 1 million human microorganisms in the next few years. The samples were sequenced and analyzed to build the world's largest human microbiome database. At the meeting, 10 scholars and experts from Sweden, Chi...

(ANN ARBOR, Mich. – January 14, 2020) Swift Biosciences, Inc. ("Swift"), a leader in design and manufacturing of unique DNA and RNA library preparation and normalization kits for Next-Generation Sequencing (NGS), and MGI Tech Co., Ltd. (MGI), a subsidiary of BGI Group, today announced a co-marketing agreement for Swift's DNA and RNA library preparation products in Europe and Asia Pacific markets. With this agreement, Swift and MGI will work to enable Swift's library preparation kits on MGI's D...

SAN FRANCISCO, CA,January 13, 2020 – MGI, one of the world’s leading manufacturers of DNA sequencing instruments, today launched its One Million Genomes Total Solution, a full-process software and hardware solution for one million genome projects. The integrated system will promote standardization and effectively solve the pain points in the industry and accelerate the arrival of the "genome for all" era, said Dr. Yongwei Zhang, BGI Group Vice President, speaking at the BUTTON Healthcare...